A growing body of evidence shows that Alzheimer’s disease differs between women and men and that to improve diagnosis and speed development of new treatments, we must better understand sex and gender differences in the disease. In May 2015, SWHR held its second interdisciplinary roundtable discussion on sex and gender differences in Alzheimer’s with 13 experts, including basic scientists, clinicians, and behavioral scientists, as well as advocates focused on the caretaker role and federal government representatives.
The meeting’s goal was to explore the state-of-the-science and discuss trends in research since SWHR’s 2011 roundtable meeting on Alzheimer’s disease. This 2015 roundtable laid the foundation for SWHR’s Alzheimer’s Disease Network and the peer-reviewed paper, Understanding the Impact of Sex and Gender in Alzheimer’s Disease: A Call to Action, published June 2018 in Alzheimer’s & Dementia.
Roberta Brinton, PhD, University of Southern California
Meryl Comer, Geoffery Beane Foundation Alzheimer’s Initiativ
Sara Czaja, PhD, University of Miami
Jeffrey Illiff, PhD, Oregon Health & Science University
Kejal Kantarci, MD, Mayo Clinic, Rochester
Nancy Lee, MD, Office of Women’s Health, U.S. Department of Health and Human Services
Pauline Maki, PhD, University of Illinois at Chicago
Mary Mittelman, DrPH, Langone Medical Center
Darby Morhardt, MSW, Northwestern University
John Morrison, PhD, Mount Sinai Hospital
Susan Resnick, PhD, National Institutes of Health
Reisa Sperling, MD, Harvard University
Duygu Tosun-Turgut, PhD, University of California at San Francisco
This program is supported by an educational sponsorship from Eli Lilly and Co.